Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance-Reference-Cited by-同舟云学术

Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance

Published:2023-10 Issue:10 Volume:36 Page:100256
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Younes Sheren^ORCID,Zhao Shuchun,Bharadwaj Sushma,Mosquera Alicia Palomino,Libert Diane,Johnsrud Andrew,Majzner Robbie G.,Miklos David B.,Frank Matthew J.,Natkunam Yasodha^ORCID

Funder

California Institute for Regenerative Medicine

STANFORD UNIVERSITY SCHOOL OF MEDICINE

Sociedad Española de Hematología y Hemoterapia

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue;Smith;J Clin Pathol,1990

2. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3;Sanchez-Madrid;Proc Natl Acad Sci USA,1982

3. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3′,5′-cyclic monophosphate production in T lymphocytes;Hahn;J Immunol,1991

4. Anti-CD3-stimulated Ca2+ signal in individual human peripheral T cells. Activation correlates with a sustained increase in intracellular Ca2+;Wacholtz;J Immunol,1993

5. CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system;Ayroldi;Blood,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerating Accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?;Seminars in Hematology;2024-09

2. Updates in the role of the tumor microenvironment cellular crosstalk and genetic signatures in diffuse large B-cell lymphoma: a narrative review;Chinese Clinical Oncology;2024-06

3. Engineering immune-evasive allogeneic cellular immunotherapies;Nature Reviews Immunology;2024-04-24

4. CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma;Cancer Research;2024

5. Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy;Immunity;2023-10